Skip to content

Oxymetholone

ALIMENTARY TRACT AND METABOLISM

Also known as: anasteron, anasteronal, nastenon, oxymethenolone, protanabol

OfmFDA approvedATC A14AA05

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Oxymetholone is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1972. DrugCentral lists 3 molecular targets, including Ar, ESR1 and AR. Recorded indications include Aplastic anemia, Congenital hypoplastic anemia and Hypoplastic anemia.

  • Approval status: ofm (first approved 1972 by the FDA).
  • Molecular targets: Ar, ESR1 and AR (3 listed in DrugCentral).
  • Indications: Aplastic anemia, Congenital hypoplastic anemia and Hypoplastic anemia.
  • ATC code: A14AA05 (Androstan derivatives).
  • Molecular formula: C21H32O3; molecular weight 332.48 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Aplastic anemia
  • Congenital hypoplastic anemia
  • Hypoplastic anemia

Contraindications (22)

  • Arteriosclerotic vascular disease
  • Benign prostatic hyperplasia
  • Blood coagulation disorder
  • Breast Carcinoma in Males
  • Breastfeeding (mother)
  • Carcinoma of female breast
  • Chronic heart failure
  • Diabetes mellitus
  • Disease of liver
  • Disorder of coronary artery
  • Edema
  • Heart disease
  • Hepatic failure
  • Humoral hypercalcemia of malignancy
  • Hypercholesterolemia
  • Hypoalphalipoproteinemia
  • Kidney disease
  • Liver function tests abnormal
  • Neoplasm of prostate
  • Nephrotic syndrome
  • Peliosis hepatis
  • Pregnancy, function

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
Androgen receptorArunknownKi 6.86
Estrogen receptorESR1unknown—
Androgen receptorARagonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1972-01-18FDA—MEDA PHARMS

ATC classification

ATC codeTherapeutic hierarchy
A14AA05ALIMENTARY TRACT AND METABOLISM › ANABOLIC AGENTS FOR SYSTEMIC USE › ANABOLIC STEROIDS › Androstan derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Oxymetholone is on its molecule page.

Molecular formulaC21H32O3
Molecular weight332.48 g/mol
CAS number434-07-1
InChIKeyICMWWNHDUZJFDW-DHODBPELSA-N
PubChem CID5281034
C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)\C(C[C@]4(C)[C@H]3CC[C@]12C)=C/O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Oxymetholone used for?

DrugCentral lists the following indications for Oxymetholone: Aplastic anemia, Congenital hypoplastic anemia and Hypoplastic anemia.

How does Oxymetholone work?

Its molecular targets in DrugCentral include Ar, ESR1 and AR (agonist).

When was Oxymetholone first approved?

Oxymetholone was first approved by the FDA in 1972.

What is the chemical formula of Oxymetholone?

Oxymetholone has the molecular formula C21H32O3 and a molecular weight of 332.48 g/mol.

Browse: all drugs starting with O · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1972-01-18
AgencyFDA
Targets3
Indications3
FormulaC21H32O3
DrugCentral ID2033
Interactive profile